Literature DB >> 15106911

Interaction of EGF family growth factors and neurotransmitters in regulating lacrimal gland secretion.

Darlene A Dartt1.   

Abstract

The lacrimal gland is the primary source for the aqueous portion of the tear film. This portion contains water, electrolytes and proteins, which are necessary for the health and maintenance of the cells of the ocular surface. Afferent sensory nerves in the cornea and conjunctiva stimulate efferent parasympathetic and sympathetic nerves in the lacrimal gland. Cholinergic agonists, released from parasympathetic nevres, and norepinephrine, released from sympathetic nerves, are major stimuli of lacrimal gland secretion. These neurotransmitters activate distinct, but overlapping signal transduction pathways leading to lacrimal gland secretion. Other stimuli of lacrimal gland secretion are the EGF family of growth factors. In addition to stimulation of secretion, these growth factors can interact with the cells of the lacrimal gland themselves or with the cells of the ocular surface depending upon the location from which these growth factors are released. This review will focus on the effects of the EGF family of growth factors on the lacrimal gland and their interactions with the pathways stimulated by the neurotransmitters released from nerves.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15106911     DOI: 10.1016/s0014-4835(03)00202-1

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  14 in total

Review 1.  Effect of inflammation on lacrimal gland function.

Authors:  Driss Zoukhri
Journal:  Exp Eye Res       Date:  2005-11-23       Impact factor: 3.467

2.  Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins.

Authors:  Robin R Hodges; Darlene A Dartt
Journal:  Exp Eye Res       Date:  2013-08-14       Impact factor: 3.467

3.  Distinct activation of epidermal growth factor receptor by UTP contributes to epithelial cell wound repair.

Authors:  Ilene Boucher; Amanuel Kehasse; Meredith Marcincin; Celeste Rich; Nader Rahimi; Vickery Trinkaus-Randall
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

4.  Identification of the Raf-1 signaling pathway used by cAMP to inhibit p42/p44 MAPK in rat lacrimal gland acini: role in potentiation of protein secretion.

Authors:  Chika Funaki; Robin R Hodges; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-07-29       Impact factor: 4.799

5.  ERK/p44p42 mitogen-activated protein kinase mediates EGF-stimulated proliferation of conjunctival goblet cells in culture.

Authors:  Marie A Shatos; Jian Gu; Robin R Hodges; Kameran Lashkari; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-17       Impact factor: 4.799

Review 6.  Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases.

Authors:  Darlene A Dartt
Journal:  Prog Retin Eye Res       Date:  2009-04-17       Impact factor: 21.198

7.  Comprehensive Proteomic Profiling of Patients' Tears Identifies Potential Biomarkers for the Traumatic Vegetative State.

Authors:  Qilin Tang; Chao Zhang; Xiang Wu; Wenbin Duan; Weiji Weng; Junfeng Feng; Qing Mao; Shubin Chen; Jiyao Jiang; Guoyi Gao
Journal:  Neurosci Bull       Date:  2018-07-18       Impact factor: 5.203

Review 8.  Image-guided evaluation and monitoring of treatment response in patients with dry eye disease.

Authors:  Yureeda Qazi; Shruti Aggarwal; Pedram Hamrah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-04       Impact factor: 3.117

Review 9.  Goblet cells: multifaceted players in immunity at mucosal surfaces.

Authors:  Kathryn A Knoop; Rodney D Newberry
Journal:  Mucosal Immunol       Date:  2018-06-04       Impact factor: 7.313

10.  Investigation of the human tear film proteome using multiple proteomic approaches.

Authors:  Kari B Green-Church; Kelly K Nichols; Nan M Kleinholz; Liwen Zhang; Jason J Nichols
Journal:  Mol Vis       Date:  2008-03-07       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.